VEGFA and osteosarcoma: In this context, using osteosarcoma cells as experimental model CCL3 was found to activate JNK, ERK and p38 and to trigger the down-regulation of miR-374b, which in turn promoted the up-regulation of VEGF and the VEGF-dependent migration and tube formation of EPCs [161].